Beijing SL Pharmaceutical Co., Ltd.
SHZ: 002038.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mingbo Xu
- Employees
- 856
- Headquarters
- Beijing, China
- IPO year
- 2004
- Market cap
- CN¥6.7B
- Website
- https://www.slpharm.com.cn
Loading 002038…
Loading profile data…Frequently asked questions about 002038
What does Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) do?
Beijing SL Pharmaceutical Co., Ltd., a biopharmaceutical company, researches, develops, produces, and markets genetic engineering and related drugs in the People's Republic of China and internationally. The company's finished formulations includes temozolomide; arsenic trioxide; lenalidomide; docetaxel; paclitaxel; filgrastim Recombinant human g...
Where does 002038.SZ trade?
Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002038.SZ in?
Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Beijing SL Pharmaceutical Co., Ltd.?
Mingbo Xu is the chief executive officer of Beijing SL Pharmaceutical Co., Ltd. (002038.SZ).
Where is Beijing SL Pharmaceutical Co., Ltd. headquartered?
Beijing SL Pharmaceutical Co., Ltd. is headquartered in China.
Does 002038.SZ pay a dividend?
Yes — Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) paid a trailing twelve-month dividend of CNY 0.02 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002038.SZ go public?
Beijing SL Pharmaceutical Co., Ltd. (002038.SZ) completed its initial public offering in 2004.